Form 4 for BMY Bristol Myers Squibb
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-04 · accession 0000014272-22-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-08 | 2022-02-04 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +3,593 | 57.5K | +7% | $0 |
| D | 2022-02-08 | 2022-02-04 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $64.99 | -1,312 | 56.2K | -2% | -$85.3K |
| D | 2022-02-08 | 2022-02-04 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | -3,593 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2022-02-04 | M | A | 3,593 | $0.00 | 57,549 | D | — | — | (F1) The restricted stock unit vests in three equal installments beginning on February 4, 2020. |
| 2 | Common | Common Stock, $0.10 par value | 2022-02-04 | F | D | 1,312 | $64.99 | 56,237 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of awards. |
| 3 | Derivative | Restricted Stock Units | 2022-02-04 | M | D | 3,593 | $0.00 | 0 | D | — · — to 2022-02-04 | 3,593 Common Stock, $0.10 par value | (F4) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock unit vests in three equal installments beginning on February 4, 2020. |